BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7403657)

  • 1. Effects of flurbiprofen on myocardial cell damage in acute myocardial ischemia.
    Smith EF; Carrow BA; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):413-33. PubMed ID: 7403657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia.
    Schrör K; Ohlendorf R; Darius H
    J Pharmacol Exp Ther; 1981 Oct; 219(1):243-9. PubMed ID: 6169823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia.
    Burke SE; Lefer DJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):76-84. PubMed ID: 6686001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of ischemic myocardium by pinane thromboxane A2.
    Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
    Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early prostaglandin release from the ischemic myocardium in the dog.
    Ogletree ML; Flynn JT; Feola M; Lefer AM
    Surg Gynecol Obstet; 1977 May; 144(5):734-40. PubMed ID: 850857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective actions of a new calcium channel blocker in acute myocardial ischemia.
    Brezinski ME; Darius H; Lefer AM
    Arzneimittelforschung; 1986 Mar; 36(3):464-6. PubMed ID: 3707665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen.
    Smith EF; Lefer AM
    Am Heart J; 1981 Apr; 101(4):394-402. PubMed ID: 7211667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of thromboxane inhibition on the severity of myocardial ischemia in cats.
    Smith EF; Lefer AM; Smith JB
    Can J Physiol Pharmacol; 1980 Mar; 58(3):294-300. PubMed ID: 7378931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375).
    Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W
    J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin-induced fever and associated haematological and blood biochemical changes in the goat: the effect of repeated administration and the influence of flurbiprofen.
    van Miert AS; van Duin CT; Verheijden JH; Schotman AJ
    Res Vet Sci; 1982 Sep; 33(2):248-55. PubMed ID: 6755596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats.
    Brezinski ME; Yanagisawa A; Darius H; Lefer AM
    Am Heart J; 1985 Dec; 110(6):1161-7. PubMed ID: 3000159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the protective effect of prostacyclin in acute myocardial ischemia.
    Ogletree ML; Lefer AM; Smith JB; Nicolaou KC
    Eur J Pharmacol; 1979 Jun; 56(1-2):95-103. PubMed ID: 467518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective actions of specific thromboxane receptor antagonist in acute myocardial ischemia.
    Brezinski ME; Yanagisawa A; Lefer AM
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):65-71. PubMed ID: 2434797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine kinase isoenzyme MB mass, cardiac troponin T, and myosin light chain isotype 1 as serological markers of myocardial injury and their prognostic importance in acute coronary syndrome.
    Ravkilde J
    Dan Med Bull; 1998 Feb; 45(1):34-50. PubMed ID: 9504265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the beneficial effect of dexamethasone on myocardial cell integrity in acure myocardial ischemia.
    Lefer AM; Crossley K; Grigonis G; Lefer DJ
    Basic Res Cardiol; 1980; 75(2):328-39. PubMed ID: 7396811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective actions of propyl gallate, a lipoxygenase inhibitor, on the ischemic myocardium.
    Leprán I; Lefer AM
    Circ Shock; 1985; 15(2):79-88. PubMed ID: 3919959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit.
    Rossoni G; Berti M; Colonna VD; Bernareggi M; Del Soldato P; Berti F
    Ital Heart J; 2000 Feb; 1(2):146-55. PubMed ID: 10730616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of platelet aggregation by 13-azaprostanoic acid in acute myocardial ischemia and sudden death.
    Burke SE; Roth DM; Lefer AM
    Thromb Res; 1983 Mar; 29(5):473-88. PubMed ID: 6857596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SP/W-5186, A cysteine-containing nitric oxide donor, attenuates postischemic myocardial injury.
    Liu GL; Christopher TA; Lopez BL; Gao F; Guo Y; Gao E; Knuettel K; Feelisch M; Ma XL
    J Pharmacol Exp Ther; 1998 Nov; 287(2):527-37. PubMed ID: 9808677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.